Effects of diabetes mellitus vs. in vitro hyperglycemia on select immune cell functions Diabetes mellitus suppresses select immune cell functions Daoud et al.

Journal of Immunotoxicology

Volumn 6, Issue 1, 2009, Pages 36-41

  Daoud, A K ^a   Tayyar, M A ^a   Fouda, I M ^a   Harfeil, N Abu ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Diabetes; Immunity; Nitroblue tetrazolium

Indexed keywords

CONCANAVALIN A; GLUCOSE; HUMAN INSULIN; MITOGENIC AGENT; NITROBLUE TETRAZOLIUM; ORAL ANTIDIABETIC AGENT; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; SUGAR;

ADULT; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POKEWEED; PRIORITY JOURNAL;

ADULT; CELL PROLIFERATION; CONCANAVALIN A; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; HUMANS; HYPERGLYCEMIA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEUTROPHILS; NITROBLUE TETRAZOLIUM; PHYTOHEMAGGLUTININS; POKEWEED MITOGENS; RESPIRATORY BURST;

PHYTOLACCACEAE;

EID: 70350452575     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.1080/15476910802604564     Document Type: Article

References (26)

1. Ananworanich, J., and Shearer, W. 2001. Immune deficiencies in congenital and metabolic diseases. In: Clinical Immunology, 2nd Edition ( Rich, R., Fleisher, T.A., Shearer, W.T., Kotzin, B.L., and Schroeder, H.W Eds), London, Mosby, Eds.pp. 42.8-42.13.
2. Andersen, B., Goldsmith, G.H., and Spagnuolo, P.J. 1988. Neutrophil adhesive dysfunction in diabetes mellitus: The role of cellular and plasma factors. J. Lab. Clin. Med. 111:275-285.
3. Balasoiu, D., van Kessel, K.C., van Kats-Renaud, H.J., Colet, T.J., and Hoepelman, A.I. 1997. Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care, 20:392-395.
4. Boyum, A. 1969. Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest. 21(S97):77.
5. Brownlee, M. 1994. Glycation and diabetic complications. Diabetes 43:836-841.
6. Casey, J.I., Heeter, B.J., and Klyshevich, K.A. 1977. Impaired response of lymphocytes of diabetic subjects to antigen of Staphylococcus aureus. J. Infect. Dis. 136:495-501.
7. Delamaire, M., Maugndre, D., Moreno, M., Le Goff, M., Allannic, H., and Genetet, B. 1997. Impaired leukocyte function in diabetic patients. Diabetic Med. 14:29-34.
8. Fontana, G., Lapolla, A., Sanzari, M., Piva, E., Mussap, M., De Toni, S., Plebani, M., Fusetti, F., and Fedele, D. 1999. An immunological evaluation of Type II diabetic patients with periodontal disease. J. Diabetes Compl. 13:23-30.
9. Gregory, R., McElveen, J., Tattersall, R.B., and Todd, I. 1993. The effects of 3-hydroxybutyrate and glucose on human T-cell responses to Candida albicans. FEMS Immunol. Med. Microbiol. 7:315-320.
10. Harbeck, R.J., and Giclas, P.C. (Eds) 1991. Lymphocyte stimulation with mitogens and antigens. In: Diagnostic Immunology Laboratory Manual, Philadelphia: Lippincott Williams and Wilkins, pp. 211-219.
11. Jones, R.L., and Peterson, C.M. 1981. Hematologic alterations in diabetes mellitus. Am. J. Med. 70:339-352.
12. Joshi, N., Caputo, G.M., Weitekamp, M.R., and Karchemer, A.W. 1999. Infection in patients with diabetes mellitus. New Engl. J. Med. 341:1906-1912.
13. Kockum, I., Wasmuth, R., and Holmberg, E. 1993. HLA-DQ primarily confers protection and HLA-DR susceptibility in Type 1 (insulin-dependent) diabetes studied in a population-based affected families and controls. Am. J. Human Genet. 53:150-167.
14. Maraton, E., Dimitriadis, G., Kollias, A., Boutati, E., Lambadiari, V., and Mitrou Band Raptis, S. 2007. Glucose transporter expression on the plasma membrane of resting and activated WBC. Eur. J. Clin. Invest. 37:282-290.
15. Mowat, A.G., and Baum, J. 1971. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. New Engl. J. Med. 284:621-627.
16. Richard, M.D., Elliot, G., Yoo Kim, W.L., Elizabeth, K., Thomas, T.A., Anthony, T.W., Michael, E.M., and Daniel, P.C. 1987. A computerassisted image-analysis system for analyzing polymorphonuclear leukocyte chemotaxis in patients with diabetes mellitus. J. Infect. Dis. 155:737-741.
17. Sensi, M., Pricci, F., Andreani, D., and Di Mario, U. 1991. Advanced nonenzymatic glycation endproducts (AGE): Their relevance to aging and the pathogenesis of late diabetic complications. Diabetes Res, 16:1-9.
18. Sentochnick, D.E. (2006). Chapter 60, Infection and diabetes. In: Joslin's Diabetes Mellitus, 14th Edition ( Kahn, C.R. Ed. ), Philadelphia: Lippincott, Williams and Wilkins, pp. 1018-1021.
19. Singh, R., Barden, A., Mori, T., and Beilin, L. 2001. Advanced glycation end products: A review. Diabetologia 44:129-146.
20. Smitherman, K.O., and Peacock, J.E. 1995. Infectious emergencies in patients with diabetes mellitus. Med. Clin. N. Amer. 79:53-77.
21. Tan, J.S., Anderson, J.L., Watanakunakorn, C., and Phair, J.P. 1975. Neutrophil dysfunction in diabetes mellitus. J .Clin. Lab. Med. 85:26-33.
22. Tater, D., Tepaut, B., Bercovici, J.P., and Youinou, P. 1987. Polymorphonuclear cell derangements in Type I diabetes. Hormone Metab. Res. 19:642-647.
23. Tuomilehto, J., Virtala, E., and Karvonen, M. 1995. Increase in incidence of insulin-dependent diabetes mellitus among children in Finland. Int. J. Epidemiol. 24:984-992.
24. Vergani, D., Johnson, C., Abdullah, N., and Barnett, A.H. 1983. Low serum C4 concentrations: An inherited predisposition to insulin dependent diabetes? Br. Med. J. 286:926-928.
25. Weiss, A., and Samelson, L.E. 2003. Chapter 11. T-Lymphocyte activation. In: Fundamental Immunology, 5th Edition, (Ed. Paul, W.E.,) Philadelphia: Lippincott, Williams, and Wilkins, pp. 321-364.
26. Wikstrom, T., Braide, M., Bagge, U., and Risberg, B. 1996. Spontaneous nitroblue tetrazolium (NBT) reduction related to granulocyte priming and activation. Inflammation 20:281-292.